Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
STU:WSG's EV-to-OCF is ranked better than 67.56% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 10.725
vs STU:WSG: 2.70
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Traditional Chinese Medicine Holdings Co (STU:WSG) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Traditional Chinese Medicine Holdings Co's PE Ratio (TTM) for today is calculated as:
China Traditional Chinese Medicine Holdings Co's share price for today is €0.22.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Traditional Chinese Medicine Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Traditional Chinese Medicine Holdings Co EV-to-OCF Related Terms
China Traditional Chinese Medicine Holdings Co EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Traditional Chinese Medicine Holdings Co EV-to-OCF Chart
China Traditional Chinese Medicine Holdings Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Traditional Chinese Medicine Holdings Co EV-to-OCF vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Traditional Chinese Medicine Holdings Co (STU:WSG) has a EV-to-OCF of 2.86 as of Aug. 01, 2026. This is 83% below median its historical median of 17.11. Over the past decade, China Traditional Chinese Medicine Holdings Co's EV-to-OCF has ranged from 2.68 to 110.30. According to the industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #327 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 32.4%.
Is China Traditional Chinese Medicine Holdings Co's EV-to-OCF too high?
China Traditional Chinese Medicine Holdings Co's current EV-to-OCF of 2.86 is 83% below median its 10-year median of 17.11. Over the past 10 years, this metric has ranged from a low of 2.68 to a high of 110.30. The Drug Manufacturers industry median EV-to-OCF is 10.73. China Traditional Chinese Medicine Holdings Co's value of 2.86 is 73.3% below this industry median. Based on the distribution chart, China Traditional Chinese Medicine Holdings Co ranks #327 out of 1008 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Traditional Chinese Medicine Holdings Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does China Traditional Chinese Medicine Holdings Co's EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #327 out of 1008 companies for EV-to-OCF. This puts China Traditional Chinese Medicine Holdings Co in the upper half of its industry. The industry median EV-to-OCF is 10.73. China Traditional Chinese Medicine Holdings Co's value of 2.86 is 73.3% below this benchmark. Historically, China Traditional Chinese Medicine Holdings Co's own EV-to-OCF has ranged from 2.68 to 110.30 over the past decade. While the company's 10-year median is 17.11 vs. the industry median of 10.73, China Traditional Chinese Medicine Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.73, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Traditional Chinese Medicine Holdings Co's current EV-to-OCF of 2.86 is 73.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Traditional Chinese Medicine Holdings Co's current EV-to-OCF is 2.86, which is 83% below median its own 10-year median of 17.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Traditional Chinese Medicine Holdings Co stock overvalued right now?
China Traditional Chinese Medicine Holdings Co (STU:WSG) has a current EV-to-OCF of 2.86. The stock's GF Value™ is €0.45, compared to a current price of €0.22 — trading 51.1% below its estimated fair value. The current EV-to-OCF is 2.86, which is 83% below median its 10-year median of 17.11 and 73.3% below the Drug Manufacturers industry median of 10.73. China Traditional Chinese Medicine Holdings Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For China Traditional Chinese Medicine Holdings Co (STU:WSG), the current EV-to-OCF is 2.86 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Traditional Chinese Medicine Holdings Co (STU:WSG) Overvalued in 2026?
Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co stock appears to be undervalued.
The current stock price of €0.22 is trading 51.1% below its estimated GF Value™ of €0.45.
Key valuation signals for STU:WSG:
EV-to-OCF: 2.86 (83% below median its 10-year median of 17.11)
GF Value™: €0.45 vs. price of €0.22 (51.1% below fair value)
Industry Position: 73.3% below the Drug Manufacturers median (#327 of 1008)
No single metric tells the full story. See the STU:WSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China, and also has its presence in Hong Kong and Other countries.
78GF Score
Get the complete analysis for STU:WSG
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WSG has been successfully added to your 
